Pizon, M.; Schott, D.; Pachmann, U.; Schobert, R.; Pizon, M.; Wozniak, M.; Bobinski, R.; Pachmann, K.
Chick Chorioallantoic Membrane (CAM) Assays as a Model of Patient-Derived Xenografts from Circulating Cancer Stem Cells (cCSCs) in Breast Cancer Patients. Cancers 2022, 14, 1476.
https://doi.org/10.3390/cancers14061476
AMA Style
Pizon M, Schott D, Pachmann U, Schobert R, Pizon M, Wozniak M, Bobinski R, Pachmann K.
Chick Chorioallantoic Membrane (CAM) Assays as a Model of Patient-Derived Xenografts from Circulating Cancer Stem Cells (cCSCs) in Breast Cancer Patients. Cancers. 2022; 14(6):1476.
https://doi.org/10.3390/cancers14061476
Chicago/Turabian Style
Pizon, Monika, Dorothea Schott, Ulrich Pachmann, Rainer Schobert, Marek Pizon, Marta Wozniak, Rafal Bobinski, and Katharina Pachmann.
2022. "Chick Chorioallantoic Membrane (CAM) Assays as a Model of Patient-Derived Xenografts from Circulating Cancer Stem Cells (cCSCs) in Breast Cancer Patients" Cancers 14, no. 6: 1476.
https://doi.org/10.3390/cancers14061476
APA Style
Pizon, M., Schott, D., Pachmann, U., Schobert, R., Pizon, M., Wozniak, M., Bobinski, R., & Pachmann, K.
(2022). Chick Chorioallantoic Membrane (CAM) Assays as a Model of Patient-Derived Xenografts from Circulating Cancer Stem Cells (cCSCs) in Breast Cancer Patients. Cancers, 14(6), 1476.
https://doi.org/10.3390/cancers14061476
